Costache M, Iordache S, Cursaru A, Popa M, Serban B, Cretu B
Cureus. 2024; 16(8):e67210.
PMID: 39295701
PMC: 11410064.
DOI: 10.7759/cureus.67210.
Qiu X, He H, Zhang C, Liu Y, Zeng H, Liu Q
World J Surg Oncol. 2024; 22(1):164.
PMID: 38914990
PMC: 11194926.
DOI: 10.1186/s12957-024-03443-0.
Ardakani A, Morgan R, Matheron G, Havard H, Khoo M, Saifuddin A
J Clin Med. 2023; 12(21).
PMID: 37959370
PMC: 10649515.
DOI: 10.3390/jcm12216905.
Gorgun B, Ozsahin M, Tok O, Davulcu C, Karaismailoglu B, Hiz M
Acta Orthop Traumatol Turc. 2022; 56(6):402-407.
PMID: 36567544
PMC: 9885716.
DOI: 10.5152/j.aott.2022.22091.
van Steenbergen T, Nijsink H, Eggen T, Janssen D, Rovers M, van der Geest I
Int J Comput Assist Radiol Surg. 2022; 18(4):775-783.
PMID: 36327031
PMC: 10039836.
DOI: 10.1007/s11548-022-02741-w.
Enchondroma in the Diaphysis of Tibia - A Case Report and Review of its Characteristics and Differentials in the Diaphysis.
Nayak K, Kulkarni M, Vijayan S, Rao S
J Orthop Case Rep. 2021; 11(7):6-11.
PMID: 34790593
PMC: 8576783.
DOI: 10.13107/jocr.2021.v11.i07.2292.
Surgical Management of Benign Tumors of the Proximal Fibula.
Huntley K, Al-Hardan W, Pretell-Mazzini J
J Am Acad Orthop Surg Glob Res Rev. 2021; 5(9).
PMID: 34515668
PMC: 8439992.
DOI: 10.5435/JAAOSGlobal-D-21-00207.
Evaluation of bone grafting for treatment of low-grade chondrosarcoma of long bones.
Zhang G, Cheon S, Park I
J Int Med Res. 2021; 49(7):3000605211025403.
PMID: 34311593
PMC: 8320587.
DOI: 10.1177/03000605211025403.
Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis.
Vuong H, Ngo T, Dunn I
Cancer Med. 2021; 10(13):4415-4423.
PMID: 34085407
PMC: 8267117.
DOI: 10.1002/cam4.4019.
Diagnosis and management of primary malignant tumors in the upper extremity.
Mackay B, McCormack R, Blank A, Bettiol P, Cox C, Brindley G
Orthop Rev (Pavia). 2021; 12(4):8345.
PMID: 33569156
PMC: 7868949.
DOI: 10.4081/or.2020.8345.
The incidence and outcome of chondral tumours as incidental findings on investigation of shoulder pathology.
Jassim S, Hilton T, Saifuddin A, Pollock R
Eur J Orthop Surg Traumatol. 2019; 30(1):97-102.
PMID: 31422474
DOI: 10.1007/s00590-019-02532-1.
Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis E, Goulding K, Stevens M, Jutte P
Cochrane Database Syst Rev. 2019; 3:CD010778.
PMID: 30845364
PMC: 6405263.
DOI: 10.1002/14651858.CD010778.pub2.
Survival and prognostic factors in conventional central chondrosarcoma.
Fromm J, Klein A, Baur-Melnyk A, Knosel T, Lindner L, Birkenmaier C
BMC Cancer. 2018; 18(1):849.
PMID: 30143018
PMC: 6109289.
DOI: 10.1186/s12885-018-4741-7.
The Significance of a "Close" Margin in Extremity Sarcoma: A Systematic Review.
Hasley I, Gao Y, Blevins A, Miller B
Iowa Orthop J. 2018; 38:123-130.
PMID: 30104934
PMC: 6047382.
Pyrroloquinoline quinone induces chondrosarcoma cell apoptosis by increasing intracellular reactive oxygen species.
Wen L, Lu X, Wang R, Jin X, Hu L, You C
Mol Med Rep. 2018; 17(5):7184-7190.
PMID: 29568949
PMC: 5928675.
DOI: 10.3892/mmr.2018.8745.
Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis.
Shemesh S, Acevedo-Nieves J, Pretell-Mazzini J
Musculoskelet Surg. 2017; 102(2):95-109.
PMID: 28986742
DOI: 10.1007/s12306-017-0507-7.
Risk factors for local recurrence from atypical cartilaginous tumour and enchondroma of the long bones.
Errani C, Tsukamoto S, Ciani G, Akahane M, Cevolani L, Tanzi P
Eur J Orthop Surg Traumatol. 2017; 27(6):805-811.
PMID: 28501961
DOI: 10.1007/s00590-017-1970-4.
Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth.
Bao X, Ren T, Huang Y, Sun K, Wang S, Liu K
Cell Death Dis. 2017; 8(2):e2605.
PMID: 28182000
PMC: 5386479.
DOI: 10.1038/cddis.2017.31.
Aberrant DNA methylations in chondrosarcoma.
Liu P, Shen J, Xu J, Trahan C, Hornicek F, Duan Z
Epigenomics. 2016; 8(11):1519-1525.
PMID: 27686001
PMC: 5289043.
DOI: 10.2217/epi-2016-0071.
Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
Bao X, Ren T, Huang Y, Wang S, Zhang F, Liu K
J Exp Clin Cancer Res. 2016; 35(1):129.
PMID: 27576314
PMC: 5006509.
DOI: 10.1186/s13046-016-0407-y.